Literature DB >> 24248942

High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease.

Akintunde O Akinkuolie1, Nina P Paynter, Latha Padmanabhan, Samia Mora.   

Abstract

BACKGROUND: Raising the cholesterol of high-density lipoprotein (HDL) particles is targeted as a cardiovascular disease prevention strategy. However, HDL particles are heterogeneous in composition and structure, which may relate to differences in antiatherogenic potential. We prospectively evaluated the association of HDL subclasses, defined by a recently proposed nomenclature, with incident coronary heart disease (CHD). METHODS AND
RESULTS: Baseline HDL particle concentrations were measured by nuclear magnetic resonance spectroscopy and categorized into 5 subclasses (very large, large, medium, small, and very small) among 26 332 initially healthy women. During a median follow-up of 17 years, 969 cases of incident CHD (myocardial infarction, revascularization, and CHD death) were ascertained. In Cox models that adjusted for age, race/ethnicity, blood pressure, smoking, postmenopausal status, and hormone therapy, associations with incident CHD were inverse (P trend<0.0001) for concentrations of very large (hazard ratio for top versus bottom quartile, 0.49; 95% confidence interval, 0.41-0.60), large (0.54; 0.45-0.64), and medium (0.69; 0.58-0.83) HDL subclasses. Conversely, hazard ratios (95% confidence intervals) for small and very small HDL were 1.22 (1.01-1.46; P trend=0.08) and 1.67 (1.39-2.02; P trend<0.0001), respectively. However, after additionally adjusting for metabolic and lipoprotein variables, associations for the spectrum of large, medium, and small HDL subclasses were inverse (P trend<0.05 for large and small and 0.07 for medium), whereas subclasses at either end of the spectrum were not associated with CHD (P trend=0.97 for very large and 0.21 for very small HDL).
CONCLUSIONS: In this prospective study, associations with incident CHD differed by HDL particle subclass, which may be relevant for developing HDL-modulating therapies. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000479.

Entities:  

Keywords:  coronary disease; epidemiology; lipids; lipoproteins

Mesh:

Substances:

Year:  2013        PMID: 24248942      PMCID: PMC4052434          DOI: 10.1161/CIRCOUTCOMES.113.000675

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  38 in total

1.  High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study.

Authors:  Bela F Asztalos; L Adrienne Cupples; Serkalem Demissie; Katalin V Horvath; Caitlin E Cox; Marcelo C Batista; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-23       Impact factor: 8.311

2.  Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.

Authors:  Sarah Parish; Alison Offer; Robert Clarke; Jemma C Hopewell; Michael R Hill; James D Otvos; Jane Armitage; Rory Collins
Journal:  Circulation       Date:  2012-04-26       Impact factor: 29.690

3.  HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men.

Authors:  J T Salonen; R Salonen; K Seppänen; R Rauramaa; J Tuomilehto
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

Review 4.  Censoring issues in survival analysis.

Authors:  K M Leung; R M Elashoff; A A Afifi
Journal:  Annu Rev Public Health       Date:  1997       Impact factor: 21.981

5.  High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

Authors:  Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

6.  Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

Authors:  B Lamarche; S Moorjani; B Cantin; G R Dagenais; P J Lupien; J P Després
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-06       Impact factor: 8.311

7.  Ischemic heart disease, atherosclerosis, and longevity.

Authors:  J W Gofman; W Young; R Tandy
Journal:  Circulation       Date:  1966-10       Impact factor: 29.690

8.  Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Sharrett; C M Ballantyne; S A Coady; G Heiss; P D Sorlie; D Catellier; W Patsch
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

9.  High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.

Authors:  J Johansson; L A Carlson; C Landou; A Hamsten
Journal:  Arterioscler Thromb       Date:  1991 Jan-Feb

10.  Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin.

Authors:  H Sugiuchi; Y Uji; H Okabe; T Irie; K Uekama; N Kayahara; K Miyauchi
Journal:  Clin Chem       Date:  1995-05       Impact factor: 8.327

View more
  23 in total

1.  Association of Air Pollution Exposures With High-Density Lipoprotein Cholesterol and Particle Number: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Griffith Bell; Samia Mora; Philip Greenland; Michael Tsai; Ed Gill; Joel D Kaufman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-04-13       Impact factor: 8.311

2.  APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.

Authors:  Orlando M Gutiérrez; Suzanne E Judd; Marguerite R Irvin; Degui Zhi; Nita Limdi; Nicholette D Palmer; Stephen S Rich; Michèle M Sale; Barry I Freedman
Journal:  Nephrol Dial Transplant       Date:  2015-07-06       Impact factor: 5.992

3.  Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort Studies.

Authors:  Parag H Joshi; Peter P Toth; Seth T Lirette; Michael E Griswold; Joseph M Massaro; Seth S Martin; Michael J Blaha; Krishnaji R Kulkarni; Arif A Khokhar; Adolfo Correa; Ralph B D'Agustino; Steven R Jones
Journal:  Eur J Prev Cardiol       Date:  2014-07-25       Impact factor: 7.804

4.  Do all components of the metabolic syndrome cluster together in U.S. Hispanics/Latinos? Results from the Hispanic Community Health study/Study of Latinos.

Authors:  Maria M Llabre; William Arguelles; Neil Schneiderman; Linda C Gallo; Martha L Daviglus; Earle C Chambers; Daniela Sotres-Alvarez; Diana A Chirinos; Gregory A Talavera; Sheila F Castaneda; Scott C Roesch; Gerardo Heiss
Journal:  Ann Epidemiol       Date:  2015-02-19       Impact factor: 3.797

5.  Low high-density lipoprotein cholesterol and particle concentrations are associated with greater levels of endothelial activation markers in Multi-Ethnic Study of Atherosclerosis participants.

Authors:  Brian T Steffen; Suzette J Bielinski; Paul A Decker; Cecilia Berardi; Nicholas B Larson; James S Pankow; Erin D Michos; Naomi Q Hanson; David M Herrington; Michael Y Tsai
Journal:  J Clin Lipidol       Date:  2017-06-13       Impact factor: 4.766

Review 6.  Role of HDL in those with diabetes.

Authors:  Carlos G Santos-Gallego; Robert S Rosenson
Journal:  Curr Cardiol Rep       Date:  2014-09       Impact factor: 2.931

7.  Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles.

Authors:  C B Dias; N Amigo; L G Wood; X Correig; M L Garg
Journal:  Eur J Clin Nutr       Date:  2017-05-10       Impact factor: 4.016

8.  HDL cholesterol and stroke risk: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Samantha A Reina; Maria M Llabre; Matthew A Allison; John T Wilkins; Armando J Mendez; Martinson K Arnan; Neil Schneiderman; Ralph L Sacco; Mercedes Carnethon; J A Chris Delaney
Journal:  Atherosclerosis       Date:  2015-09-28       Impact factor: 5.162

Review 9.  From High-Density Lipoprotein Cholesterol to Measurements of Function: Prospects for the Development of Tests for High-Density Lipoprotein Functionality in Cardiovascular Disease.

Authors:  Frank M Sacks; Majken K Jensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-25       Impact factor: 8.311

10.  Polyphenol rich olive oils improve lipoprotein particle atherogenic ratios and subclasses profile: A randomized, crossover, controlled trial.

Authors:  Sara Fernández-Castillejo; Rosa-Maria Valls; Olga Castañer; Laura Rubió; Úrsula Catalán; Anna Pedret; Alba Macià; Maureen L Sampson; María-Isabel Covas; Montserrat Fitó; Maria-José Motilva; Alan T Remaley; Rosa Solà
Journal:  Mol Nutr Food Res       Date:  2016-05-06       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.